MarketInOut Stock Screener Log In | Sign Up
 

Cytosorbents Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/16/2026 16:00
Cytosorbents Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9.36 mln
Float2.71 mln
Earnings Date10/29/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.88
Highly reliable

1-Year Forecast

47.50
Transformational upside

Relative Strength

81 / 100
Strongly outperforming

Pre-Tax Margin

-50%
Deeply loss-making

ROE

-326
Deeply negative

Business Description

Founded in 1997 and based in Princeton, New Jersey, Cytosorbents Corporation develops and sells medical devices built around a specialized polymer technology that filters harmful substances from the blood. Its best-known product, CytoSorb, is used in hospital settings to treat serious conditions such as sepsis, organ failure, and complications arising from heart surgery. The company also offers a range of related products targeting drug removal, veterinary care, organ preservation, and blood compatibility, serving customers across the United States, Germany, and other international markets.

Key Fundamentals

EPS-5.18
ROE-326
RPS11.86
ROIC-31.76
ROA-41.41
Interest Cover-8.86
EBITDA, mln-13.96
EV / EBITDA-2.74
EV / EBIT-2.47
Revenue, mln37.22
EV / Revenue1.03

Quote Details

Last 4.11
Change 1.05 (34.31%)
Open 3.01
Volume 640,269
Turnover 2,631,506
Average Volume 41,370

Financial Ratios

Pre-Tax Profit Margin-50
Current Ratio0.66
Price / Sales0.34

Financial Strength

Altman Z-Score-12.3
Piotroski F-Score 5 / 9
Beneish M-Score-3.88
1-Year Target Price47.50
Short Ratio4.71
Short % of Float4.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.44% 97 / 100   
1 Month -28.65% 11 / 100   
2 Months -45.92% 10 / 100   
6 Months -68.86% 7 / 100   
1 Year -77.57% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us